学术探索
学术期刊
新闻热点
数据分析
智能评审

NEW DRUG DEVELOPMENT IN THE UNITED-STATES, 1963 THROUGH 1984

被引：41
作者：
MATTISON, N
TRIMBLE, AG
LASAGNA, L
机构：
[1] TUFTS UNIV,CTR STUDY DRUG DEV,136 HARRISON AVE,BOSTON,MA 02111
[2] TUFTS UNIV,DEPT PSYCHIAT,BOSTON,MA 02111
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1988年 / 43卷 / 03期
关键词：
D O I：
10.1038/clpt.1988.35
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：290 / 301
页数：12
相关论文
共 5 条
[1]   NEW DRUG DEVELOPMENT DURING AND AFTER A PERIOD OF REGULATORY CHANGE - CLINICAL RESEARCH ACTIVITY OF MAJOR UNITED-STATES PHARMACEUTICAL FIRMS, 1958 TO 1979 [J].
MAY, MS ;
WARDELL, WM ;
LASAGNA, L .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (06) :691-700
[2]   SUCCESS RATES IN THE UNITED-STATES DRUG DEVELOPMENT SYSTEM [J].
SHECK, L ;
COX, C ;
DAVIS, HT ;
TRIMBLE, AG ;
WARDELL, WM ;
HANSEN, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :574-583
[3]   DEVELOPMENT OF NEW DRUGS ORIGINATED AND ACQUIRED BY UNITED-STATES-OWNED PHARMACEUTICAL FIRMS, 1963-1976 [J].
WARDELL, WM ;
DIRADDO, J ;
TRIMBLE, AG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :270-277
[4]  
WARDELL WM, 1978, CLIN PHARMACOL THER, V24, P133
[5]   NEW DRUG DEVELOPMENT BY UNITED-STATES PHARMACEUTICAL FIRMS WITH ANALYSES OF TRENDS IN THE ACQUISITION AND ORIGIN OF DRUG CANDIDATES, 1963-1979 [J].
WARDELL, WM ;
MAY, MS ;
TRIMBLE, AG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (04) :407-417
1